Additionally, improving CAR-T biological efficiency could reduce dosing needs, further cutting costs and expanding access.

Researchers have found that tapping into the body's own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of tumor-infiltrating ...